Drug targeting ebola virus protein VP24 shows promise in monkeys

An experimental medication that targets a protein in Ebola virus called VP24 protected 75 percent of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the US Army, in collaboration with Sarepta Therapeutics, Inc. The study was published this week in mBio, the online open-access journal of the American Society for Microbiology. —> Read More Here

facebooktwittergoogle_plusredditpinterestlinkedinmail

Leave a Reply

Your email address will not be published. Required fields are marked *